Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Veno-arterial extracorporeal membrane oxygenation in cardiogenic shock
Session:
Sessão de Posters 40 - Pós-paragem cardíaca e desfechos na UCI cardíaca
Speaker:
Marta Catarina Almeida
Congress:
CPC 2026
Topic:
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
Theme:
14. Acute Cardiac Care
Subtheme:
14.4 Acute Cardiac Care – Cardiogenic Shock
Session Type:
Posters Eletrónicos
FP Number:
---
Authors:
Marta Catarina Ferreira de Almeida; André Lobo; Marta Leite; Inês Neves; Adelaide Dias; Marisa Silva; Marta Ponte; Pedro Teixeira; Gualter Silva; Ricardo Fontes-Carvalho
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-family:"Arial",sans-serif">Background:</span></strong><span style="font-family:"Arial",sans-serif"> Veno-arterial extracorporeal membrane oxygenation (ECMO) is a mechanical circulatory support (MCS) used in patients with cardiogenic shock (CS).</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-family:"Arial",sans-serif">Purpose:</span></strong><span style="font-family:"Arial",sans-serif"> The aim of the study was to identify predictors of ECMO implantation.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-family:"Arial",sans-serif">Methods:</span></strong><span style="font-family:"Arial",sans-serif"> Retrospective analysis of CS patients in a cardiac unit in 5 years was conducted. Comorbidities, diagnosis, analytic data at presentation, SCAI classification, MCS used, and 30-days and 1-year mortality were registered. Chi-square, Mann-Whitney and logistic regression were used.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-family:"Arial",sans-serif">Results:</span></strong><span style="font-family:"Arial",sans-serif"> In 175 patients with CS, 25 had ECMO implantation. A comparison of patients with and without ECMO use is in Table 1.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="font-family:"Arial",sans-serif">Age was lower in patients with ECMO (56 <em>versus</em> 71 years, p <0.001). History of hypertension (OR = 0.288, p = 0.008), dyslipidemia (OR = 0.375, p = 0.030), diabetes (OR = 0.216, p = 0.011) and atrial fibrillation (OR = 0.837, p = 0.047) were negatively associated with ECMO implantation. Diagnosis (R<sup>2</sup> = 0.213, p = 0.002) and SCAI classification (R<sup>2</sup> = 0.185, p <0.001) correlated with ECMO. Lower systolic blood pressure (p = 0.033) and higher lactate levels (p = 0.002) were verified in patients submitted to ECMO. Logistic regression predicted ECMO use (R<sup>2</sup> 0.534, p<0.001), but only age (p 0.006) and SCAI classification (p 0.016) remained significant in the multivariable model. Intra-aortic balloon pumps (IABP) or Impella® heart pump use was higher in ECMO patients (OR = 2.623, p = 0.041). Mortality was different only at 30-days (OR 2.667, p 0.028).</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><strong><span style="font-family:"Arial",sans-serif">Conclusion: </span></strong><span style="font-family:"Arial",sans-serif">Younger age and greater initial severity as reflected by higher SCAI classification were independent predictors of ECMO implantation</span>.<span style="font-family:"Arial",sans-serif"> Patients older and with comorbidities had lower odds of ECMO support. Patients supported tended to have severe hemodynamic compromise (class E of SCAI in almost half, lower systolic blood pressure, higher lactate levels, higher need for IABP/Impella®). These findings highlight tailored ECMO implantation selection primarily driven by patient age and shock severity at presentation.</span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site